Reducing Postoperative Ileus

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

POI Definitions Consensus Panel (cont)

POI Criteria

POI Pathophysiology Mechanisms

POI Pathophysiology Phases

Epidemiology of POI

POI Impact

Risk Factors for POI

Modifiable Risk Factors for POI

Risk Factors for POI Surgical Approach

Risk Factors for POI Associated With Colon Surgery

POI Prophylaxis Perioperative Nutrition

POI Prophylaxis Anesthesia Considerations

POI Prophylaxis Goals

POI Prophylaxis Pharmacologic Agents

POI Prophylaxis Meta-analysis in Abdominal Operations

POI Prophylaxis Pooled Analysis of Alvimopan Trials

POI Prophylaxis Results of Meta-analysis in Abdominal Operations

POI Prophylaxis Meta-analysis in Radical Cystectomy

ERAS Definition

The Impact of ERAS on POI

ERAS Components Preoperative

ERAS Components Intraoperative

ERAS Components Postoperative

Adding Alvimopan to ERAS

Conclusions

Abbreviations